Youssef Bennani is a co-managing partner at CTI Life Sciences Fund who leads their Inception-2-Inflection strategy, focusing on creating and building companies from the ground up and staying involved through advanced clinical development rather than only backing later, de-risked assets. He brings an uncommon combination of senior big-pharma R&D leadership experience from Vertex Pharmaceuticals and early-stage venture creation experience, having served simultaneously as Chief Scientific Officer and Venture Partner at adMare BioInnovations where he was involved in establishing multiple new life sciences companies.